Stay updated with breaking news from Steve Varga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Although the common and highly-contagious RSV – short for “respiratory syncytial virus” – runs a mild, cold-like course for most people, it can hit infants and patients over 60 hard, even requiring hospitalization. For the first time, a vaccine is how available for those high-risk groups – thanks, in part, to University of Iowa Health Care trial work.
BlueCrest has unveiled OttoMate, it’s first-ever collaborative robot, engineered to work alongside human operators to automate various tasks in the mail production work cell. OttoMate is programable, allowing for an infinite canvas of future automation that scales beyond traditional manually intensive tasks.
University of Iowa researchers say an RSV vaccine could be approved by federal officials within the next two years.
University of Iowa researchers say an RSV vaccine could be approved by federal officials within the next two years.
/PRNewswire/ -- Innoveo, a global technology firm and a pioneer in enterprise no-code platform today announced that Safety Insurance Group, an A.M. Best rated...